Christopher Chavez is an accomplished inventor based in Santa Cruz, California. He has made significant contributions to the field of gene therapy and biotechnology, holding three patents that showcase his innovative spirit and dedication to advancing medical science.

Latest Patents

One of his latest patents is focused on ELOVL2 constructs for human gene therapy. This patent discloses therapeutic agents capable of increasing the expression level of ELOVL2. Additionally, it describes agents that reduce or slow an aging phenotype, along with methods for treating age-related eye diseases or conditions. Another notable patent involves mutant viral capsid libraries and related systems and methods. This patent provides mutant viral capsid cell libraries, individual cells of such libraries, systems, vectors, and methods for generating the cell libraries. It also includes methods of use to screen for mutant viral capsids with desired characteristics.

Career Highlights

Christopher has worked with prominent companies in the biotechnology sector, including Adverum Biotechnologies, Inc. and Visgenx, Inc. His work in these organizations has allowed him to contribute to groundbreaking research and development in gene therapy.

Collaborations

Throughout his career, Christopher has collaborated with talented individuals such as Mehdi Gasmi and Annahita Keravala. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Christopher Chavez is a notable inventor whose work in gene therapy and biotechnology continues to influence the field. His patents reflect a commitment to addressing age-related health issues and advancing therapeutic techniques.

Profile summary based on public USPTO records.